Clinical Trials Browser

Phase 1/2 × OTHER_GOV × CNS × Clear all

NCT07264569 2025-12-04

Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

Phase 1/2 Recruiting

Meningeal Carcinomatosis

NCT02430363 2016-02-24

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Phase 1/2 Unknown

Glioblastoma, Gliosarcoma

NCT02050243 2014-01-30

5-ALA

Phase 1/2 Unknown

Brain Neoplasms, Central Nervous System Neoplasms